Single Capsule Bismuth Quadruple Therapy for Eradication of H. pylori Infection: A Real-Life Study

Background and aim: Bismuth quadruple therapy (BQT) or non-bismuth quadruple therapy (i.e., concomitant therapy) (CT) is the first-line regimens to eradicate H. pylori infection in areas with high prevalence of clarithromycin (CLA) resistance. Guidelines suggest that in areas of high prevalence of H...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Front Pharmacol
Auteurs principaux: Gravina, Antonietta G., Priadko, Kateryna, Granata, Lucia, Facchiano, Angela, Scidà, Giuseppe, Cerbone, Rosa, Ciamarra, Paola, Romano, Marco
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2021
Sujets:
Pharmacology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8118713/
https://ncbi.nlm.nih.gov/pubmed/33995097
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2021.667584
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires